The Cost of Lost Science: How DeSci Can Prevent Decades of Delay

Getting your Trinity Audio player ready...

Scientific progress does not stop only when an experiment fails. It also stops when a laboratory runs out of money, a grant committee rejects an unconventional proposal, or a researcher is pushed away from the work because the expected results appear too uncertain.

The cost is larger than a missed publication. A delayed discovery can mean years of avoidable illness, slower technological development, lost economic productivity, and generations of researchers unknowingly rebuilding ideas that could already have been tested.

Lost science is valuable research that remains unfinished, unpublished, or unused because the people pursuing it cannot obtain sustained resources. Decentralized science, or DeSci, cannot guarantee that every unconventional idea is correct. It can, however, create additional funding channels so that one committee, university, government, or corporation does not have the power to end an entire line of inquiry.

When the Future of Computing Lost Its Funding

In nineteenth-century Britain, Charles Babbage designed machines that anticipated essential features of modern computing.

His Difference Engine was intended to calculate and print mathematical tables automatically. His more ambitious Analytical Engine was a general-purpose programmable machine with separate components resembling memory and a processor. It incorporated concepts now described as conditional branching, loops, input, output, and a fetch-execute cycle.

The British government initially financed Babbage’s work. Construction of the Difference Engine stopped in 1832 after a dispute with engineer Joseph Clement, and government funding was finally terminated in 1842. The Analytical Engine was never completed during Babbage’s lifetime.

The Computer History Museum’s account of Babbage’s engines notes that the logical structure of the Analytical Engine closely resembled the architecture later used by electronic computers. Yet automatic programmable computing would not become operational reality until roughly a century later.

It would be too simple to claim that one cancelled grant single-handedly postponed the computer revolution for a hundred years. Nineteenth-century manufacturing, electronics, mathematics, and demand were not yet ready for modern computing. Babbage also repeatedly changed his designs and had serious project-management disputes.

Nevertheless, the episode demonstrates a fundamental problem:

When an ambitious research project depends on a single patron, the withdrawal of that patron can terminate the project regardless of the long-term value of its underlying ideas.

A decentralized funding network could not have supplied nineteenth-century electronics. It might, however, have financed smaller prototypes, independent verification, clearer documentation, and continued development by other engineers. Instead of one enormous government contract, the project could have been divided into testable milestones funded by different supporters.

The Long Road to mRNA Medicine

The history of messenger RNA provides a more recent example of a potentially transformative technology struggling to attract stable support.

Scientists recognized that synthetic mRNA might instruct cells to produce useful proteins. In principle, this could enable vaccines and treatments without permanently changing DNA. In practice, early mRNA was unstable and could provoke damaging inflammatory responses.

Katalin Karikó continued working on therapeutic mRNA despite repeated difficulty obtaining grant support. Her lack of funding contributed to her precarious academic position, while the field remained far from the scientific mainstream. Karikó and Drew Weissman eventually discovered that specific modifications to mRNA could reduce unwanted immune activation—a foundation for later mRNA vaccines.

Their work was recognized with the 2023 Nobel Prize in Physiology or Medicine. A peer-reviewed historical review describes Karikó’s career as being constrained partly by persistent funding difficulties, even as she continued developing the technology.

The eventual success of mRNA did not emerge without public support. A study published in The BMJ estimated that the United States invested at least $31.9 billion in the development, production, and purchase of mRNA COVID-19 vaccines, including substantial investment in the scientific foundations of the technology.

This distinction matters. The lesson is not that traditional institutions never support revolutionary science. They often do. The lesson is that they may support it heavily after years of uncertainty, once technical feasibility, commercial value, or political urgency becomes clearer.

By that point, much time may already have been lost.

Institutions are generally better at scaling a recognized breakthrough than at protecting an unrecognized one.

DeSci addresses this earliest and most fragile stage. A researcher who cannot win a large conventional grant may still receive small contributions from patients, scientists, technical communities, nonprofit organizations, or donors who consider the experiment worth testing.

Helicobacter pylori: When Evidence Challenged Medical Consensus

For much of the twentieth century, physicians commonly associated peptic ulcers with stress, lifestyle, and excessive stomach acid. Robin Warren and Barry Marshall instead investigated spiral bacteria found in the stomach.

In 1982, they cultivated the organism later named Helicobacter pylori and connected it to gastritis and peptic ulcer disease. Their findings ultimately transformed ulcer treatment: many patients could be treated with antibiotics rather than relying indefinitely on acid-suppressing medication.

The Nobel Assembly later concluded that the discovery converted peptic ulcer disease from a frequently chronic and disabling condition into a disease that could often be permanently cured. Marshall and Warren received the 2005 Nobel Prize in Physiology or Medicine.

This case was not simply a story of zero funding. Marshall and Warren obtained limited research support, and scientific skepticism was reasonable while the evidence remained incomplete. However, the work illustrates how an unconventional hypothesis can struggle when it contradicts an established explanatory model.

Funding and acceptance interact. A theory regarded as implausible receives fewer resources. With fewer resources, researchers produce evidence more slowly. Slow evidence production then reinforces the belief that the theory is unimportant.

This creates a feedback loop:

1. An idea conflicts with conventional expectations.
2. Reviewers classify it as unlikely or low priority.
3. The project receives insufficient funding.
4. Researchers cannot produce decisive evidence quickly.
5. The absence of decisive evidence is interpreted as evidence that the project lacks merit.

DeSci cannot determine in advance whether such a theory is true. It can make the cost of obtaining an initial answer much lower.

The Discoveries We Cannot Name

Historical success stories create a selection problem. We know about mRNA, H. pylori, and Babbage because their ideas eventually survived.

We do not know how many researchers abandoned valid hypotheses because they could not pay for equipment, computing, publication, data collection, or basic living expenses. We cannot list discoveries that disappeared without leaving enough evidence to be recognized.

This is the deepest cost of lost science.

A terminated project may represent:

• an experiment that was never repeated;
• a dataset that was never collected;
• software that remained an unfinished prototype;
• a mathematical manuscript that was never reviewed;
• a treatment that never entered preclinical testing;
• or a young researcher who permanently left science.

These losses are difficult to measure precisely because the counterfactual result does not exist. There is no citation count for an unpublished idea and no economic estimate for a medicine that was never developed.

Science-policy researchers sometimes call neglected but socially valuable research “undone science.” Work on rare diseases, environmental hazards, public health, and low-profit technologies can remain underdeveloped when affected communities lack sufficient economic or institutional influence. Research on rare-disease funding, for example, has examined how patient organizations and other interest groups can mobilize resources for topics that established systems previously neglected.

Why Traditional Grant Systems Lose Promising Science

Conventional grants remain essential. Laboratories need large, predictable budgets, and expert review can filter technically impossible or poorly designed projects.

The problem is excessive dependence on a narrow set of gatekeepers.

Proposal quality can replace scientific value

Grant applications evaluate work before its results exist. Reviewers must therefore rely on proxies: institutional affiliation, publication history, preliminary results, references, reputation, and the persuasiveness of the proposal.

These signals contain useful information, but they favor researchers who already possess funding, institutional support, grant-writing experience, and access to preliminary data.

A researcher may need funding to generate preliminary evidence while simultaneously needing preliminary evidence to obtain funding.

Committees rationally avoid unusual risks

Review panels must justify their decisions and distribute limited budgets. Supporting a conventional project that fails may appear defensible. Supporting an unfamiliar project that fails may appear irresponsible.

This creates incentives to fund ideas located near an accepted consensus rather than ideas that could change it.

Funding arrives in large, slow packages

Traditional grants may take months to prepare, review, approve, and release. Many research problems do not initially require a multimillion-dollar program. They require a small amount immediately: access to a dataset, laboratory supplies, cloud computing, travel to an archive, or several weeks of focused work.

When only large grants are available, small but decisive experiments can remain unfunded.

Institutional rejection becomes total rejection

A proposal rejected by one agency may be submitted elsewhere, but many agencies rely on similar credentials, publication indicators, and disciplinary categories. Formally separate institutions can therefore reproduce the same blind spots.

The result is centralized judgment without a single central authority.

How DeSci Changes the Funding Architecture

Decentralized science uses open digital infrastructure, distributed communities, blockchain systems, and alternative evaluation mechanisms to organize research funding and collaboration.

Its central advantage is not that crowds are always wiser than experts. Its advantage is funding pluralism.

A project rejected by a traditional committee can remain visible and receive support from other sources.

Micro-grants can keep experiments alive

A researcher may not need a complete multiyear grant. A relatively small payment can purchase reagents, run a simulation, compensate a technical contributor, or produce the preliminary result required for larger funding.

This reduces the all-or-nothing character of scientific finance.

Instead of asking, “Should this researcher receive enough money for an entire program?” a donor can ask, “Is the next verifiable experiment worth funding?”

Funding can follow demonstrated contribution

Traditional grants largely finance promises. DeSci systems can also reward completed work: open datasets, reproducible experiments, software, proofs, reviews, replications, and documented negative results.

The AI Internet-Meritocracy model proposed by Science DAO aims to distribute resources according to AI-assessed contributions and observable research impact rather than relying exclusively on degrees, institutional prestige, or conventional grant applications.

This approach does not eliminate judgment. It changes its object. Instead of primarily judging a researcher’s status and predictions, it attempts to evaluate evidence of useful work.

Open records preserve abandoned ideas

A public, timestamped research record can preserve hypotheses, protocols, code, data, and partial results even when the original team stops working.

Another researcher can inspect the record, reproduce the experiment, correct an error, or continue the project. The first attempt does not disappear inside an abandoned institutional account or an unpublished notebook.

Global donors can support neglected fields

Traditional research budgets are usually constrained by national priorities, university strategies, disciplinary boundaries, and commercial markets.

DeSci allows support to cross these boundaries. Patients may finance rare-disease research. Software users may support open infrastructure. Mathematicians may fund foundational work that has no immediate commercial application. Small donors from many countries may collectively support an experiment ignored by every individual institution.

Transparent infrastructure can reduce dependency on intermediaries

Blockchain-based systems can provide auditable transaction histories and programmable allocation rules. Future migration to non-custodial wallets can further reduce reliance on a central organization holding donor funds.

This does not automatically make funding fair or scientifically correct. Smart contracts can contain errors, governance can be captured, and evaluation algorithms can reproduce bias. Transparency nevertheless allows researchers and donors to inspect rules that would otherwise remain hidden inside committee deliberations.

DeSci Does Not Abolish Scientific Evaluation

Funding every unconventional claim would not protect science. It would waste resources and make fraud easier.

A credible DeSci system still needs:

• transparent eligibility rules;
• conflict-of-interest disclosure;
• identity and contribution verification;
• reproducibility checks;
• fraud detection;
• qualified specialist review;
• milestone-based payments;
• and procedures for challenging evaluations.

AI evaluation also requires safeguards. Models can misread specialized research, reward superficial signals, or be manipulated by strategically written submissions. AI alignment and resistance to evaluation gaming are therefore part of the funding problem, not optional technical details.

The objective is not to replace one unquestionable authority with another. It is to build a system in which assessments are inspectable, contestable, and supplemented by multiple independent funding decisions.

Prevention, Not a Promise

It would be inaccurate to say that DeSci can prevent every delayed breakthrough.

Some research is delayed because the necessary instruments do not exist. Some theories lack supporting evidence. Some projects are badly managed. Some scientific questions require infrastructure too expensive for distributed microfunding. In other cases, traditional skepticism is correct.

DeSci addresses a narrower but important failure:

A scientifically testable idea should not disappear merely because it fails to fit the priorities of a small number of institutions.

The strongest model is therefore hybrid. Governments and universities can finance expensive infrastructure and long-term programs. Companies can scale technologies with commercial applications. DeSci can discover, preserve, and support projects that these systems overlook—especially during the period when an idea is too unconventional to be institutionally safe and too early to be commercially profitable.

The Real Price of Waiting

The visible cost of underfunding is the amount missing from a research budget. The true cost is measured in time.

For computing, it may be decades before a neglected architecture is rebuilt under another name. For medicine, it may be years of preventable disease before an unconventional mechanism is accepted. For mathematics and basic science, an overlooked conceptual tool may delay entire chains of dependent discoveries.

Funding science is therefore not simply an act of generosity toward researchers. It is a decision about how long society is willing to wait for knowledge that may already be within reach.

Donations to independent science can create additional paths between an idea and its first decisive test. The value of decentralized funding is not that it knows which forgotten researcher will eventually be proved right.

Its value is that fewer researchers must disappear before society has a chance to find out.